Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Tissue Science 2017

About Congress

The 6th International conference  on Tissue Engineering and Regenerative Medicine which is going to be held during August 23-24 2017 at San Francisco,California, USA. Will bring together world-class personalities working on stem cellstissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. Bone tissue engineeringsoft tissuestissue imagingtissue implant, cartilage and skin defects are a special focus along with applying basic science and engineering principles from diverse areas towards solving clinically relevant biomedical problems. Conference series LLC Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharmacy  and Science and Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies  and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

We welcome you to Tissue Science Conference, to be held on December 01-02, 2016 in San Antonio, USA. This conference presents information regarding cutting-edge developments in all areas of tissue engineering, stem cell research, regenerative medicine research including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.

After the success of the Global congress on Tissue Engineering and Regenerative Medicine Conference in 2016, it is time once again for the tissue engineering and regenerative medicine industries to come together and this time look forward to the next 10 years of commercial successes within these two sectors.

The World Conference on Regenerative Medicine  has traditionally focussed on developing the commercial aspects of  tissue science research, with the addition of innovation within stem cells, regenerative medicine, notably tissue engineering.

Now the first regenerative medicine therapies have made it to market, it is important, for the success of the sector, to move forward and include new projects and innovations that are coming out of academia and university spin-outs. These will be both new developments in regenerative medicine research but also within the use of tissue engineering and stem cells for drug discovery.

Alongside the stem cells content, there is an increasing amount of demand for other forms of regenerative medicine and so the Tissue Science conference will move to include more commercial opportunities within the field of tissue engineering: markedly biological scaffolds, 3D bio printing and organ regeneration.

Through the last 5 years the Tissue Science Conference has built up a reputation for delivering high-level commercial content and bringing together the senior executives and thought-leaders within the space.

Market Analysis

USA: Regenerative medicines market by therapy (cell therapy, gene therapy, immunotherapy, tissue engineering), region - global forecast to 2021, the global regenerative medicines market size is expected to reach USD 49.41 billion by 2021,. north america contributed the largest share in the global regenerative medicines market, and was dominated largely by the u.s.

 

Europe: The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, Today, there are 640  privately held and  publicly traded companies  in Europe, Japan, and the U.S.

 

 

Middle East: Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma.

 

Asia Pacific: Asia-Pacific regenerative medicines market is expected to reach USD 10.71 billion by 2021 from USD 3.01 billion in 2016, growing at a CAGR of 28.90% during the forecast period 2016-2021.  cell-based products segment is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2016

 

Market Analysis Report:

 

 

Sessions And Tracks

 

Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe hold the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

 

The  Global Congress on Tissue Engineering and Regenerative Medicine which is going to be held during December 01-02, 2016 at San Antonio, USA will bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. 

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for tissue science which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signalling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion by 2024.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ;5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Tissue Niches and Resident Stem Cells in Adult Epithelia Gordon Research Conference, Regulation of Tissue Homeostasis  by Signalling in the Stem Cell Niche  August 7-12, Hong Kong, China; 10 Years of IPSCs, Cell Symposia, September 25-27, 2016 Berkeley, CA, USA; World Stem Cells and Regenerative Medicine Congress May 18-20, 2016 London, UK; Notch Signaling in Development, Regeneration and Disease Gordon Research Conference,  July 31-August 5, 2016 Lewiston, ME, USA

 

Biological Tissue Substitutes

Bioengineered skin and soft tissue substitutes may be derived from human tissue (autologous or allogeneic), nonhuman tissue (xenographic), synthetic materials, or a composite of these materials. Bioengineered skin and soft tissue substitutes are being evaluated for a variety of conditions, including breast reconstruction and healing lower-extremity ulcers and severe burns. Acellular dermal matrix (ADM) products are also being evaluated for soft tissue repair.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Bio-banking August 18-19, 2016 Portland, USA; ISSCR Annual Meeting 22-25 June, 2016 San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 – 7, 2016 Snowbird, Utah, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

 

Organ Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5thInternational Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Trends in Tissue Engineering

Although several major progresses have been introduced in the field of bone regenerative medicine during the years, current therapies, such as bone grafts, still have many limitations. Moreover, and in spite of the fact that material science technology has resulted in clear improvements in the field of bone substitution medicine, no adequate bone substitute has been developed and hence large bone defects/injuries still represent a major challenge for orthopaedic and reconstructive surgeons. It is in this context that TE has been emerging as a valid approach to the current therapies for bone regeneration/substitution. In contrast to classic biomaterial approach, TE is based on the understanding of tissue formation and regeneration, and aims to induce new functional tissues, rather than just to implant new spare partsRelated Conferences

5th International Conference Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation August 18-19, 2016 Portland, USA; Molecular and Cellular Basis of Growth and Regeneration (A3) January 10 – 14, 2016 Colorado, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease March 13 – 17, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; World Stem Cells Congress May 18-20, 2016 London, UK; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA.

 

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centred on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signalling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteon and chondrogenic potential.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 3rd 2nd International Conference on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 5thInternational Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 10th World Biomaterials Congress May 17-22, 2016 Quebec, Canada; 2016 TERMIS-EU Conference June 28- July1, 2016 Uppsala, Sweden; 2016 TERMIS-AP Conference  Tamsui Town of New Taipei City May 23-28, 2016; 2016 TERMIS-AM Conference September 3-6, 2016, San Diego, USA; Pluripotency: From basic science to therapeutic applications 22-24 March 2016 Kyoto, Japan

 

Cell Culture & Bio Reactors

Bioreactors come in a variety of sizes, shapes, and forms. Single-use bioreactors for cell culture were introduced to the market in the mid-90s and they are now widely used in process development, research, and manufacturing up to 2000 L scale. Disposable technology brings an increased speed and flexibility to bioprocessing and decreases cleaning validation costs.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Patient Specific Drug Discovery

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Bio-banking August 18-19, 2016 Portland, USA; ISSCR Annual Meeting 22-25 June, 2016 San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 – 7, 2016 Snowbird, Utah, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

 

Tooth Regeneration

Tooth regeneration is a stem cell based regenerative medicine procedure in the field of tissue engineering and stem cell biology to replace damaged or lost teeth by regrowing them from autologous stem cells.

As a source of the new bioengineered teeth somatic stem cells are collected and reprogrammed to induced pluripotent stem cells which can be placed in the dental lamina directly or placed in a reabsorbable biopolyme in the shape of the new tooth .

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, US;  International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Tissue Niches and Resident Stem Cells in Adult Epithelia Gordon Research Conference, Regulation of Tissue Homeostasis by Signalling in the Stem Cell Niche  August 7-12, Hong Kong, China; 10 Years of IPSCs, Cell Symposia, September 25-27, 2016 Berkeley, CA, USA; World Stem Cells and Regenerative Medicine Congress May 18-20, 2016 London, UK; Notch Signaling in Development, Regeneration and Disease Gordon Research Conference,  July 31-August 5, 2016 Lewiston, ME, USA

 

Regenerative medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. The latest developments involve advances in cell and gene therapy and stem cell research, molecular therapy, dental and craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th Intern01-02,2016 at San Antonio, USA.

 

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centred on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signalling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteon and chondrogenic potential.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 3rd 2nd International Conference on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 5thInternational Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 10th World Biomaterials Congress May 17-22, 2016 Quebec, Canada; 2016 TERMIS-EU Conference June 28- July1, 2016 Uppsala, Sweden; 2016 TERMIS-AP Conference  Tamsui Town of New Taipei City May 23-28, 2016; 2016 TERMIS-AM Conference September 3-6, 2016, San Diego, USA; Pluripotency: From basic science to therapeutic applications 22-24 March 2016 Kyoto, Japan

 

Cell Culture & Bio Reactors

Bioreactors come in a variety of sizes, shapes, and forms. Single-use bioreactors for cell culture were introduced to the market in the mid-90s and they are now widely used in process development, research, and manufacturing up to 2000 L scale. Disposable technology brings an increased speed and flexibility to bioprocessing and decreases cleaning validation costs.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Patient Specific Drug Discovery

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International 

Past Conference Report

Tissuescience 2016

Tissue Science 2016 Report

Global Congress on Tissue Engineering and Regenerative Medicine was organized during August 01-02, 2016 at n Antonio, USA. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Addressing New Challenges & Emerging Issues in Regenerative Medicine and its Allied Areas”. which included the following scientific tracks:

Stem Cells
Stem Cell Treatments
Rejuvenation
Stem Cell Transplant
Cell Engineering
Bone Tissue Engineering
Tissue preservation
Regenerative Medicine
Tissue Repair and Regeneration
Embryonic Stem Cell
Gene Therapies
Biomaterials and Bioengineering
Models of Regeneration
Tissue Engineering
Scaffolds in Regenerative Medicine
Cellular Therapies
Ethical and Legal Issues
Translational Medicine

The Organizing Committee would like to thank the moderator Dr. Margaret Simonian (University of Californian Los Angeles, USA) for her contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Ken Yaegaki- Regenerated liver from human tooth pulp treats swine liver failure started by NAFLD (The Nippon Dental University, Japan)

Jia-Qiang He - Cardiac endothelial progenitor cell promotes angiogenesis in mouse hindlimb ischemia (Virginia Tech, USA)

Makoto Komura- Patch tracheoplasty by in body tissue engineering using collagenous connective tissue membranes (biosheets) (Saitama Medical University, Japan)

Margaret Simonian- Proteomics Analysis of Brain Avm Endothelium Post Radiosurgery In Pursuit Of Targets for Molecular Therapies (University of Californian Los Angeles , USA)

Jerry Ray Burgess-  An Integrated Approach To Target Deconvolution, Target Engagement, And Compound Characterization In Live Cells (St. Cloud State University, USA)

Various sessions were chaired and co-chaired by: Jia-Qiang He- Virginia Tech, USA; Petra Perner - Institute of Computer Vision and Applied Computer Sciences, Germany ;

ConferenceSeries LLC has taken the privilege of felicitating Tissue Science 2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Tissue Science 2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Tissue Science & engineering: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the " 2nd Global Congress on Tissue Engineering and Regenerative Medicine " to be organized during August 23,24 at San Francisco, USA.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 23-24 , 2017

Speaker Opportunity

Supported By

Journal of Tissue Science & Engineering Journal of Biomimetics Biomaterials and Tissue Engineering Journal of Cell Science & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by